CHMP Gave Positive Opinions To Update The Composition Of The Moderna's MRNA Vaccine Spikevax1, To Target SARS-COV-2 JN.1 Variant Of The Virus That Causes Covid-19
CHMP Gave Positive Opinions To Update The Composition Of The Moderna's MRNA Vaccine Spikevax1, To Target SARS-COV-2 JN.1 Variant Of The Virus That Causes Covid-19
CHMP對moderna的MRNA疫苗Spikevax1的成分進行了更新，以針對引發Covid-19的SARS-COV-2 JN.1變種發表了積極意見。
CHMP Gave Positive Opinions To Update The Composition Of The Moderna's MRNA Vaccine Spikevax1, To Target SARS-COV-2 JN.1 Variant Of The Virus That Causes Covid-19
CHMP對moderna的MRNA疫苗Spikevax1的成分進行了更新，以針對引發Covid-19的SARS-COV-2 JN.1變種發表了積極意見。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間